Wellcome at Molecular Diagnostics Group
Molecular Diagnostics Group (MDG) is the company association of Biotype Diagnostic, Biotype Innovation, qualitype and ROTOP Pharmaka, which combines expertise in molecular diagnostics, radiopharmaceutical theranostics, and bioinformatics. Our overall aim is to develop innovative methods for analysis and diagnostics within life science.
MOLECULAR BIOLOGICAL TEST SYSTEMS
MOLECULAR DIAGNOSTIC ASSAYS
SOFTWARE SOLUTIONS FOR LABORATORY & PRODUCTION
RADIOPHARMACEUTICAL PRODUCTS
Biotype Diagnostic GmbH
Biotype Diagnostic GmbH has been developing, producing, and selling high-quality test systems for molecular diagnostics since 1999. In close cooperation with scientific experts in the field of life sciences and guided by international design control processes (Design Control Guidance), Biotype transfers scientific results into the marketable products and is a partner to laboratories (IVD products) and industrial customers (contract development & manufacturing).
Biotype Innovation GmbH
Biotype Innovation GmbH was founded in 2015 as a joint venture of QIAGEN GmbH and the Biotype Diagnostic GmbH. The biotech company develops and sells molecular diagnostic assays based on the fully automated Modaplex technology. These tests are used in various areas of Life Science, such as personalized medicine, pharmaceutical research and in-vitro diagnostics (IVD). In addition, the company provides customized services in the areas of product development, production and sample analysis.
qualitype GmbH
The qualitype GmbH is a software system supplier for digital laboratory and manufacturing processes. Since 2001, qualitype develop specialized software products and implement individual software- and consulting projects internationally. In the areas of laboratory management (LIMS), analytics and supply chain, we offer distinguished professional- and technical advisory expertise.
ROTOP Pharmaka GmbH
ROTOP Pharmaka is a leading German pharmaceutical company that produces cGMP compliant radiopharmaceuticals for diagnostics and therapy in Nuclear Medicine and Molecular Imaging and distributes them in more than 30 countries worldwide. With almost 20 years of experience in the development, production, authorization and distribution of sterile kits for radiolabeled pharmaceuticals ROTOP continuously expands its product portfolio by developing new products and entering new strategic partnerships.
Management
+49 351 8838 400
+49 351 8838 4500
+49 351 8838 2800
+49 351 26 310 0